SickKids Expands Azure Use in Five Year Microsoft Deal
Oct 20, 2026
Healthcare
BC Platforms and AWS Sign Collaboration to Advance Healthcare Data Analytics
May 5, 2026
BC Platforms has signed a strategic collaboration agreement with Amazon Web Services to accelerate healthcare and life sciences innovation through enhanced data analytics and AI capabilities within its BC Mosaic platform.
BC Platforms has signed a strategic collaboration agreement with Amazon Web Services to expand access to its healthcare data analytics tools and support innovation in life sciences, announced in a press release.
The agreement will strengthen BC Platforms' AI powered solutions within its BC Mosaic trusted research environment, which runs on AWS infrastructure. BC Mosaic enables organizations to manage and analyze sensitive clinical and genomic data securely while connecting to external datasets from BC Platforms' global network of more than 150 data partners.
Through the collaboration, BC Platforms will enhance the speed and scale of multi modal data analysis and provide tools for organizations preparing for European Health Data Space compliance. The platform, available through AWS Marketplace, supports research institutions and healthcare providers with cloud based analytics and regulatory grade data environments.
The companies will also engage in joint go to market activities, including co selling initiatives and research consortia, to extend BC Platforms' reach among hospitals, clinics, and national health systems.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 13 ETR survey: Claude leads enterprise AI tools on satisfaction and spending plans Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 Gondola says Codex lifted engineering output 25% as revenue more than doubled Nov 13 DuPont teams with Microsoft and NobleAI to speed up R&D with AI Nov 13 Korean AI startups fear Huang exit could delay planned NVIDIA investmentsMore from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
AstraZeneca and Oracle Partner on AI for Clinical Trials
Oct 20, 2026
Healthcare
Azra AI Acquires Blackford Analysis
Oct 20, 2026
Acquisitions
BioMap Announces 11 AI Life Science Collaborations
Nov 12, 2026
Life Sciences
BioStack Raises $9.5 Million for Medical AI Data Network
Oct 22, 2026
Funding
Illumina Launches BioInsight Platform for Genomic Research
Oct 14, 2026
Biotech
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.